drugset / Trial / NCT04292197

A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers

NCT04292197

Phase 1 Completed 108 enrolled Definium Therapeutics US, Inc.
RandomizedSequentialDouble-blindTreatment

Summary

The primary objective of this study is to assess the safety and tolerability of a single day dosing and a separate multiple day dosing of 18-MC HCl administered orally, each part of the study having a different set of healthy male and female volunteers.

Timeline

Start
2020-04-14
Primary completion
2021-12-13
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 18-Methoxycoronaridine Unknown Oral

Indications